Neurology News

Echocardiographic measures of lower left atrial function were significantly associated with an increased risk of subsequent dementia, experts reported in JAMA.

Medication and exercise are more beneficial in preventing a second stroke in those with intracranial atherosclerosis compared with placement of a blood vessel stent, new guidance from the American Academy of Neurology stated.

National Cancer Institute announced the launch of a program that offers molecular characterization of childhood cancers.

Telestroke networks improve acute stroke treatment for veterans and positively affect the efficiency of interhospital networks by avoiding unnecessary ED transfers, according to a study published in Neurology.

Autoimmune treatments accounted for more than half of all specialty drug growth in 2021, according to a drug trend report released by CVS Health.

Sage Therapeutics Inc. announced positive results from a phase 2 trial for an oral treatment that was linked to improvements in functioning, learning and memory in those with mild cognitive impairment from Parkinson’s disease.

Health care providers said they feel undervalued and unsatisfied with the current health care system, and many are considering leaving the workforce, according to Elsevier Health’s first “Clinician of the Future” report.

Recent findings published in JAMA Network Open validate a blood test that uses biomarkers to determine the severity of a traumatic brain injury and whether a CT scan is warranted.

Glucocorticoids can do a lot of harm over time. In this episode, John Stone, MD, MPH, walks us through the Glucocorticoid Toxicity Index, a validated tool to measure steroid toxicity over time that we’ll be seeing more of in the future.

Almost 16 million Americans who enrolled in Medicaid during the public health emergency could lose coverage when the emergency declaration ends if it expires after the third quarter of 2022.